Intraductal Papillary Mucinous Neoplasm With Malignant Change

N/ATerminatedNCT02044926

Asan Medical Center54 enrolled

Overview

Purpose: To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012. Hypothesis: According to 2012 consensus guidelines, enhanced solid component and main pancreatic duct size of larger than 10 mm will be significant.

1. Purpose * To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012 2. Enroll criteria * Patient who is suspected to have pancreas IPMN on imaging * Interval between imaging study and surgery is less than 2 months * Who is scheduled for surgery due to IPMN

Study Type

OBSERVATIONAL

Enrollment

Conditions

IPMN

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who is suspected to have IPMN by imaging study or clinician * Time interval between imaging study and surgery less than 2 months Exclusion Criteria: * Patients who have pathology results not by surgery * Who is less than 20 years old * Who cannot voluntarily agree study design

Locations (1)

Asan Medical Center

Seoul, South Korea

Outcomes

Primary Outcomes

Imaging predictor of malignant IPMN of the pancreas

We will assess baseline CT and MRI findings of patients within one month after surgery.

Time frame: one month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.